# Axsome Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:679fa766-02b6-4718-b6a0-a23c624077b1 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/axsome-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 17 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-22T04:45:35.101896+00:00 | | Last reviewed | 2026-10-22T04:45:35.101896+00:00 | ## Identity - Legal name: Axsome Therapeutics, Inc. - Display name: Axsome Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-23T04:44:58.090476+00:00 | | Completeness | 0.364 | | Record Quality | 0.846 | | Directors | 6 | | Committees | 0 | | Governance events | 12 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | NOT_REVIEWED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Ari Maizel, M.B.A.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-24. claim_id=alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:6 - Herriot Tabuteau, M.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-24. claim_id=alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:7 - Hunter Murdock, Esq.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-24. claim_id=alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:8 - Mark Coleman: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2014-01-01. claim_id=alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:9 - Mark Saad: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2014-01-01. claim_id=alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:10 - Roger Jeffs: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2014-01-01. claim_id=alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:11 ## Executive leadership - Ari Maizel, M.B.A.: Chief Commercial Officer. Status: current. claim_id=alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:12 - Herriot Tabuteau, M.D.: Chief Executive Officer, President, and Chairman of the Board [CEO]. Status: current. claim_id=alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:13 - Hunter Murdock, Esq.: General Counsel [GC]. Status: current. claim_id=alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:14 - Mark Jacobson: Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:15 - Mark Jacobson, M.A.: Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:16 - Nick Pizzie, C.P.A., M.B.A.: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:17 ## Governance events - DIRECTOR_APPOINTED: Ari Maizel, M.B.A. seat on Axsome Therapeutics, Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-22T04:45:35.101896+00:00. event_id=alpha:event:transition:k0t9ohuvd2p - DIRECTOR_APPOINTED: Herriot Tabuteau, M.D. seat on Axsome Therapeutics, Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-22T04:45:35.101896+00:00. event_id=alpha:event:transition:agd1qekutr6s - DIRECTOR_APPOINTED: Hunter Murdock, Esq. seat on Axsome Therapeutics, Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-22T04:45:35.101896+00:00. event_id=alpha:event:transition:vmx4tj1isa4zb - EXECUTIVE_APPOINTED: Ari Maizel, M.B.A. executive of Axsome Therapeutics, Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-22T04:45:35.101896+00:00. event_id=alpha:event:transition:1ac64wekd58mi - CEO_CHANGED: Herriot Tabuteau, M.D. executive of Axsome Therapeutics, Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-22T04:45:35.101896+00:00. event_id=alpha:event:transition:71a92u3nfvyy - GC_CHANGED: Hunter Murdock, Esq. executive of Axsome Therapeutics, Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-22T04:45:35.101896+00:00. event_id=alpha:event:transition:ie4p761xcfxvk - EXECUTIVE_APPOINTED: Mark Jacobson executive of Axsome Therapeutics, Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-22T04:45:35.101896+00:00. event_id=alpha:event:transition:11wi8wvjz96gr - EXECUTIVE_APPOINTED: Mark Jacobson, M.A. executive of Axsome Therapeutics, Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-22T04:45:35.101896+00:00. event_id=alpha:event:transition:16xoy3u29rfrs - CFO_CHANGED: Nick Pizzie, C.P.A., M.B.A. executive of Axsome Therapeutics, Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-22T04:45:35.101896+00:00. event_id=alpha:event:transition:7h938e96a2z2 - DIRECTOR_APPOINTED: Mark Coleman seat on Axsome Therapeutics, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-22T04:45:35.101896+00:00. event_id=alpha:event:transition:1j81ckn1qd0gp5 - DIRECTOR_APPOINTED: Mark Saad seat on Axsome Therapeutics, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-22T04:45:35.101896+00:00. event_id=alpha:event:transition:cgq971rrk0gl - DIRECTOR_APPOINTED: Roger Jeffs seat on Axsome Therapeutics, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-22T04:45:35.101896+00:00. event_id=alpha:event:transition:15yl1t61eczaj4 ## Scoped resources - `alpha://company/axsome-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record - `alpha://company/axsome-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=identity - `alpha://company/axsome-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/axsome-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=board - `alpha://company/axsome-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=committees - `alpha://company/axsome-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=leadership - `alpha://company/axsome-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=ownership - `alpha://company/axsome-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=financials - `alpha://company/axsome-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/axsome-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=compensation - `alpha://company/axsome-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=governance - `alpha://company/axsome-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/axsome-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=audit - `alpha://company/axsome-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=legal - `alpha://company/axsome-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=risk - `alpha://company/axsome-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=cyber - `alpha://company/axsome-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/axsome-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=agents - `alpha://company/axsome-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/axsome-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=events - `alpha://company/axsome-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=relationships - `alpha://company/axsome-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=assessments - `alpha://company/axsome-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Ari Maizel, M.B.A.: Director. Claim: alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:6. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f32c28ca970e6aa87ac929b1d08f33993775557f36e4b86d6ec2236eaeb7cea9. - Herriot Tabuteau, M.D.: Director. Claim: alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:7. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f32c28ca970e6aa87ac929b1d08f33993775557f36e4b86d6ec2236eaeb7cea9. - Hunter Murdock, Esq.: Director. Claim: alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:8. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f32c28ca970e6aa87ac929b1d08f33993775557f36e4b86d6ec2236eaeb7cea9. - Mark Coleman: Director. Claim: alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:9. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f32c28ca970e6aa87ac929b1d08f33993775557f36e4b86d6ec2236eaeb7cea9. - Mark Saad: Director. Claim: alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:10. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f32c28ca970e6aa87ac929b1d08f33993775557f36e4b86d6ec2236eaeb7cea9. - Roger Jeffs: Director. Claim: alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:11. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f32c28ca970e6aa87ac929b1d08f33993775557f36e4b86d6ec2236eaeb7cea9. - Ari Maizel, M.B.A.: Chief Commercial Officer. Claim: alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:12. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:39d5fe2e1a9245358df50f682690a56ea2ed97479f72fc3c151a06f2e13cb784. - Herriot Tabuteau, M.D.: Chief Executive Officer, President, and Chairman of the Board. Claim: alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:13. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cb35528bba51c99718c52825c92c8437c2a9014c0f5c002bb1971bffe4b27812. - Hunter Murdock, Esq.: General Counsel. Claim: alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:14. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cb6e910055e7b9cd37fb32d5b038f43af007c26ae9c2cc4d50e869f123c979fa. - Mark Jacobson: Chief Operating Officer. Claim: alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:15. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f32c28ca970e6aa87ac929b1d08f33993775557f36e4b86d6ec2236eaeb7cea9. - Mark Jacobson, M.A.: Chief Operating Officer. Claim: alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:16. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f5d6eb3dcce9b78b96fd4e9c841d85b1eafc4be8624760bd0dec7428c8b04b0e. - Nick Pizzie, C.P.A., M.B.A.: Chief Financial Officer. Claim: alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:leadership_role:17. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eacdac4e97a841d55cdfa02c275bb79b75653fbfb166fb359f39830ed15e4631. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Axsome Therapeutics, Inc.. Claim: alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d4c4772b1089a6bcafe6ed35bfd33f2debd4eaac9c915a85b082b675c75f41a1. ## Entity Status - Public listing published. Claim: alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d4c4772b1089a6bcafe6ed35bfd33f2debd4eaac9c915a85b082b675c75f41a1. ## Published Fact - US. Claim: alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d4c4772b1089a6bcafe6ed35bfd33f2debd4eaac9c915a85b082b675c75f41a1. - Healthcare. Claim: alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d4c4772b1089a6bcafe6ed35bfd33f2debd4eaac9c915a85b082b675c75f41a1. ## Security Listing - AXSM (NASDAQ). Claim: alpha:claim:company:679fa766-02b6-4718-b6a0-a23c624077b1:security_listing:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d4c4772b1089a6bcafe6ed35bfd33f2debd4eaac9c915a85b082b675c75f41a1. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:d4c4772b1089a6bcafe6ed35bfd33f2debd4eaac9c915a85b082b675c75f41a1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/axsome-therapeutics-inc). - alpha:projection-evidence:document:f32c28ca970e6aa87ac929b1d08f33993775557f36e4b86d6ec2236eaeb7cea9: [DEF 14A axsm-20260424.htm](https://www.sec.gov/Archives/edgar/data/1579428/000119312526177610/axsm-20260424.htm). - alpha:projection-evidence:document:39d5fe2e1a9245358df50f682690a56ea2ed97479f72fc3c151a06f2e13cb784: [AXSM DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1579428/000119312526177610/axsm-20260424.htm). - alpha:projection-evidence:document:cb35528bba51c99718c52825c92c8437c2a9014c0f5c002bb1971bffe4b27812: [AXSM DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1579428/000119312526177610/axsm-20260424.htm). - alpha:projection-evidence:document:cb6e910055e7b9cd37fb32d5b038f43af007c26ae9c2cc4d50e869f123c979fa: [AXSM DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1579428/000119312526177610/axsm-20260424.htm). - alpha:projection-evidence:document:f5d6eb3dcce9b78b96fd4e9c841d85b1eafc4be8624760bd0dec7428c8b04b0e: [AXSM DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1579428/000119312526177610/axsm-20260424.htm). - alpha:projection-evidence:document:eacdac4e97a841d55cdfa02c275bb79b75653fbfb166fb359f39830ed15e4631: [AXSM DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1579428/000119312526177610/axsm-20260424.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/axsome-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/axsome-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/axsome-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/axsome-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-23T04:44:57.869177+00:00; recorded 2026-10-23T04:44:57.869177+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.